Hypogonadotropic hypogonadism-frontoparietal alopecia syndrome

Hypogonadotropic hypogonadism-frontoparietal alopecia syndrome, also known as Frontoparietal alopecia with hypogonadotropic hypogonadism, is an extremely rare genetic condition characterized by the combination of hypogonadotropic hypogonadism and a distinctive pattern of hair loss affecting the frontal and parietal regions of the scalp. Hypogonadotropic hypogonadism refers to reduced function of the gonads (testes or ovaries) due to insufficient production of gonadotropin-releasing hormone (GnRH) or gonadotropins (LH and FSH) from the hypothalamus or pituitary gland. This leads to delayed or absent puberty, reduced fertility, and in males, possible micropenis or cryptorchidism. The alopecia component involves progressive hair thinning and loss predominantly over the front and top of the head. The syndrome affects the endocrine and integumentary (skin/hair) systems. Clinical features typically become apparent around the time of expected puberty, when affected individuals fail to develop secondary sexual characteristics. The alopecia may present earlier or concurrently. Only a small number of families have been reported in the medical literature, making it one of the rarest described genetic syndromes. Treatment is primarily supportive and symptomatic, focusing on hormone replacement therapy to induce puberty and maintain secondary sexual characteristics. Gonadotropin therapy or pulsatile GnRH administration may be used to promote fertility when desired. There is no specific treatment for the alopecia component, though cosmetic options may be considered.

Common questions about Hypogonadotropic hypogonadism-frontoparietal alopecia syndrome